Market News Video
MNV MNV 10 Stocks Crossing Above Their 200 Day Moving Average
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Top Buys by Directors: Ingram's $2M Bet on SRPT
Monday, January 29, 12:08 PM ET, by Market News Video Staff

The directors of a company tend to have a unique inside view into the business, ...

We Did The Math XBI Can Go To $119
Thursday, February 1, 8:34 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Portola Pharmaceuticals (PTLA) Shares Cross Below 200 DMA
Friday, February 2, 4:59 PM ET, by Market News Video Staff

In trading on Friday, shares of Portola Pharmaceuticals, Inc. (PTLA) crossed below their 200 day ...

Notable ETF Outflow Detected - XBI, BIVV, MDXG, JUNO
Tuesday, February 6, 11:05 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, BIVV, MDXG, JUNO Exchange traded funds (ETFs) trade just ...

Clovis Oncology Enters Oversold Territory (CLVS)
Thursday, February 8, 12:29 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Affymax Inc Becomes Oversold (AFFY)

By Market News Video Staff, Thursday, February 14, 1:05 PM ET
Play Video: Learn About The RSI

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of Affymax Inc (AFFY) entered into oversold territory, hitting an RSI reading of 28.4, after changing hands as low as $11.26 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 75.3. A bullish investor could look at AFFY's 28.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of AFFY shares:

Affymax Inc 1 Year Performance Chart

Looking at the chart above, AFFY's low point in its 52 week range is $9.98 per share, with $27.74 as the 52 week high point that compares with a last trade of $16.05. Find out what 9 other oversold stocks you need to know about

According to the ETF Finder at ETF Channel, AFFY makes up 1.29% of the SPDR S&P Biotech ETF (AMEX:XBI) which is trading lower by about 0.4% on the day Thursday.

See what other ETFs contain AFFY
See what other stocks are held by XBI

Special Offer: Find out what Dave Moenning is holding in the ETF Channel Flexible Growth Investment Portfolio with 30 Days Free.

This Article's Word Cloud:   AFFY   AMEX   About   According   Affymax   Biotech   Buffett   Channel   Dave   Days   ETFs   Find   Finder   Flexible   Free   Growth   Index   Investment   Know   Legendary   Looking   Moenning   Offer   Oversold   Portfolio   Relative   Thursday   about   below   chart   fearful   greedy   investor   look   other   others   oversold   point   reading   share   shares   stock   stocks   that   trading   week   what   when   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Portfolio Channel Stock Market Definitions

Affymax Inc Becomes Oversold (AFFY) | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.